Washington, D.C. 20549



FORM 12b-25



SEC File Number: 001-38588

CUSIP Number: 68373M107




(Check one): ☐ Form 10-K ☒ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D
  ☐ Form N-CEN ☐ Form N-CSR      
  For Period Ended: December 31, 2020      
  ☐ Transition Report on Form 10-K      
  ☐ Transition Report on Form 20-F      
  ☐ Transition Report on Form 11-K      
  ☐ Transition Report on Form 10-Q      
  For the Transition Period Ended:      


Read Instructions (on back page) Before Preparing Form. Please Print or Type.

Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.


If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:




Opera Limited
Full Name of Registrant
Former Name if Applicable
Vitaminveien 4
Address of Principal Executive Office (Street and Number)
Oslo, NO-0485, Norway
City, State and Zip Code


PART II RULES 12b-25(b) AND (c)


If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b- 25(b), the following should be completed. (Check box if appropriate)


  (a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-CEN or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
  (c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.




State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-CEN, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.




The Company is filing this Form 12b-25 with the Securities and Exchange Commission (the “SEC”) to postpone the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2020 beyond April 30, 2021, the prescribed due date for such filing.


As indicated in Company's first quarter 2021 earnings release dated April 27, 2021, the Company is in an advanced stage of preparing the annual report, including consolidated financial statements for the period ended December 31, 2020. The Company’s investee, Nanobank, is conducting its first annual closing of IFRS figures across all of its active markets, and the related external audit under PCAOB auditing standards, upon which we rely in finalizing our reporting on Form 20-F. Nanobank’s location in India has in particular seen closing process impacts from the local COVID-19 resurgence which have affected both Nanobank’s staff and its external audit team, resulting in significant delays in completing all required processes. Due to the foregoing, Nanobank has not been able to complete its reporting to the Company, with the result that the Company has been unable to finalize its consolidated financial statements within the prescribed time period for Form 20-F. The Company expects to file its Form 20-F on or before the fifteenth calendar day following the prescribed due date.






Name and telephone number of person to contact in regard to this notification

Frode Jacobsen   +47   2369-2400
(Name)   (Area Code)   (Telephone Number)



Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If answer is no, identify report(s).


☒ Yes ☐ No



Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?


☐ Yes ☒ No


If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.


Opera Limited
(Name of Registrant as Specified in Charter)


has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.


Date May 3, 2021   By /s/ Frode Jacobsen
        Frode Jacobsen
        Chief Financial Officer


INSTRUCTION: The form may be signed by an executive officer of the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.


Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).